<DOC>
	<DOCNO>NCT00129402</DOCNO>
	<brief_summary>This randomize , double-blind , control , parallel-group , multicenter , Phase-3 study evaluate efficacy safety ezetimibe simvastatin take alone subject ages 10-17 year Heterozygous Familial Hypercholesterolemia .</brief_summary>
	<brief_title>Effects Ezetimibe With Simvastatin Therapy Adolescents With HeFH ( Study P02579 )</brief_title>
	<detailed_description>This study consist 3 distinct period . In Period 1 , subject receive daily treatment 6 week part either ezetimibe simvastatin group part simvastatin monotherapy group . Subjects ezetimibe simvastatin group receive one three treatment : coadministration ezetimibe 10 mg/day plus simvastatin 10 mg/day , 20 mg/day , 40 mg/day . Subjects simvastatin monotherapy group receive one three treatment : ezetimibe placebo plus simvastatin 10 mg/day , 20 mg/day , 40 mg/day . The primary key secondary efficacy analysis base evaluation perform Period 1 present data subject pool either ezetimibe simvastatin treatment group compare data subject pool simvastatin monotherapy treatment group . In Period 2 , subject receive ezetimibe 10 mg/day plus simvastatin 40 mg/day ezetimibe placebo plus simvastatin 40 mg/day 27 additional week maintain treatment assignment ( coadministration v monotherapy ) Period 1 . In Period 3 , subject receive ezetimibe 10 mg/day plus open-label simvastatin daily 20 week .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Adolescent ( age 10 17 year ) boys girls weigh least 88 lb ( 40 kg ) . Subjects must high cholesterol ( low density lipoprotein cholesterol [ LDLC ] 159 mg/dL 4.1 mmol/L ) family history high cholesterol . Subjects diagnose delayed puberty . Subjects sensitive simvastatin and/or ezetimibe . Subjects drink alcohol excessively history alcohol drug abuse within past 2 year . Subjects know HIV positive , undergoing LDL apheresis plasma apheresis , partial ileal bypass .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>drug</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>adolescent</keyword>
	<keyword>randomize controlled trial</keyword>
</DOC>